# #544: Updated Pulmonary Embolism Guidelines

An episode of [The Curbsiders Internal Medicine Podcast](https://invisiblenetwork.ai/podcast/1198732014), 26 Oct 2026, 1 h 17 min.

Audio: https://clrtpod.com/m/pscrb.fm/rss/p/dts.podtrac.com/redirect.mp3/audioboom.com/posts/8969004.mp3?modified=1792983581&sid=5034728&source=rss

Review the latest 2026 AHA/ACC multisociety pulmonary embolism guidelines with us, including risk stratification, new clinical categories, acute and extended anticoagulation, advanced therapies, follow-ups, and more. We are joined by Drs. Cyrus Askin and Nick Mark from Critical Care Time! Claim CME for this episode here: https://ce.vcuhealth.org/curbsiders! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments • Intro • Initial assessment and diagnostic approach to PE • Evolution of PE classification systems • Acute PE treatment • Advanced therapies • Duration of anticoagulation • Post-discharge follow-up • Chronic thromboembolic disease • Outro Credits • Producer, writer, show notes, infographic, and cover art: Edison Jyang, MD • Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP • Reviewer: Sai S Achi MD,MBA,FACP • Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP • Technical Production: PodPaste • Guest: Cyrus Askin, MD; Nick Mark, MD Disclosures Dr. Cyrus Askin reports financial disclosures with Astra Zeneca, Speakers Bureau. The Curbsiders report no relevant financial disclosures. Sponsor: FIGS Get 15% off your first order at wearfigs.com with the code FIGSRX. Sponsor: CONTINUING EDUCATION COMPANY Visit CMEmeeting.org/curbsiders Use promo code Curb30 for 30% off all online courses and webcasts. Sponsor: Panacea Financial Visit panaceafinancial.com/curbsiders to talk with a Practice Finance Specialist about what you're planning next.

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them.